CDH1 and cancer: The results of germline genetic testing in a single commercial laboratory in over 200,000 probands with a variety of cancers reported a significant enrichment of germline CDH1 PV in patients with colorectal adenocarcinoma (CRC) and signet ring cell cancer when compared to a cancer-free population [5, 6].